Nanovaccine Institute
The Nanovaccine Institute, established at Iowa State University in 2017, is a national transdisciplinary research consortium focused on advancing nano-based technologies to treat and prevent diseases. The institute aims to revolutionize public health outcomes through the design and promotion of nano-based vaccines and therapeutics.
Nanovaccine Institute
5001 ATRB, 2213 Pammel Drive, Ames, IA 50011-1101
What We Do
Developing nanovaccines for various diseases including respiratory infections, cancer, and antimicrobial resistance.
Creating nanotherapeutics to treat neurodegenerative diseases such as Alzheimer's and Parkinson's.
A universal influenza nanovaccine designed to be effective against multiple strains of flu.
Researching and developing vaccines for veterinary diseases that can also inform human health solutions.